NDC 80425-0237-01 - Diclofenac Sodium
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 80425-0237
- Requested NDC
- 80425-0237-01
- Package NDCs from labels
- 80425-0237-1, 80425-0237-01
- Manufacturer
- Advanced Rx Pharmacy of Tennessee, LLC
- Effective date
- 2024-12-31
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Diclofenac Sodium - Advanced Rx Pharmacy of Tennessee, LLC | Advanced Rx Pharmacy of Tennessee, LLC | 2024-12-31 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80425-0237-1 | Diclofenac Sodium | 150 mL in 1 BOTTLE | SOLUTION | 150 | 4 | |
| 80425-0237-1 | Diclofenac Sodium | 1 in 1 CARTON | SOLUTION | 1 | 4 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 80425-0237 | DICLOFENAC SODIUM SOLUTION [ADVANCED RX PHARMACY OF TENNESSEE, LLC] | 4 | Current NDC, 2 package rows | 20250102_f1896c84-b18a-d49d-e053-2995a90aaab3.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 80425-0237-1 | ML - Milliliter | 80425-0237 | e028fbd8-98bc-4f4a-97fa-fd08d74407b3 | 1 | 2023-03-13 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| DICLOFENAC SODIUM | DICLOFENAC SODIUM | Aurobindo Pharma Limited | 3487033c-7c62-4034-8718-73a7c49b26a0 | 2025-05-09 | Boxed warning, Warnings, Adverse reactions | QTG126297Q |
| Diclofenac Sodium | DICLOFENAC SODIUM | PD-Rx Pharmaceuticals, Inc. | 87d5a720-f154-4c4b-b2d4-0ae58455dda0 | 2025-05-05 | Boxed warning, Warnings, Adverse reactions | QTG126297Q |
| Diclona | LIDOCAINE 4.5%, DICLOFENAC 1% | Advanced Rx of Tennessee, LLC | 34685ef2-0015-8941-e063-6294a90ad0f7 | 2025-05-05 | Warnings, Adverse reactions | QTG126297Q |
| DICLOFENAC SODIUM | DICLOFENAC SODIUM TOPICAL GEL, 1% | Dr. Reddy's Laboratories Inc. | 03abebd6-426a-9d05-3dff-196477389430 | 2025-05-05 | Warnings | QTG126297Q |
| Diclofenac sodium | DICLOFENAC SODIUM | BluePoint Laboratories | 896e3f7d-88e6-4563-b879-a2757d19fd62 | 2025-05-02 | Boxed warning, Warnings, Adverse reactions | QTG126297Q |
| DICLOFENAC SODIUM | DICLOFENAC SODIUM | Advagen Pharma Ltd | 72419a68-4c9d-44e0-9b43-922440e2c8d7 | 2025-04-30 | Warnings, Adverse reactions | QTG126297Q |
| up and up arthritis pain reliever | DICLOFENAC SODIUM | Target Corporation | 0b7ae58c-cdaf-4343-a199-7a90bf901eb5 | 2025-04-27 | Warnings | QTG126297Q |
| Diclofenac Sodium | DICLOFENAC SODIUM | NorthStar Rx LLC | c7431496-c0ef-403a-9716-92d942709b3d | 2025-04-25 | Boxed warning, Warnings, Adverse reactions | QTG126297Q |
| Diclofenac Sodium and Misoprostol | DICLOFENAC SODIUM AND MISOPROSTOL | Amneal Pharmaceuticals LLC | afd30051-8f59-474b-9972-962a5a871dfb | 2025-04-22 | Boxed warning, Warnings, Adverse reactions | QTG126297Q |
| Diclofenac Sodium | DICLOFENAC SODIUM | GERI-CARE PHARMACEUTICAL CORP | fc08e58c-6323-e667-e053-6394a90ab754 | 2025-04-21 | Warnings | QTG126297Q |
| Diclofenac Sodium | DICLOFENAC SODIUM | RedPharm Drug, Inc. | 4ecb7bdc-4a5e-7444-e054-00144ff88e88 | 2025-04-09 | Boxed warning, Warnings, Adverse reactions | QTG126297Q |
| Diclona | LIDOCAINE 4.5%, DICLOFENAC 1% | Clinic Pharma | 3271f9ee-6f8a-1c68-e063-6394a90a8e3b | 2025-04-08 | Warnings, Adverse reactions | QTG126297Q |
| Diclofenac Sodium | DICLOFENAC SODIUM | Bryant Ranch Prepack | 487fa223-f4d9-4ab1-a5af-fb0d93f2bd0e | 2025-03-28 | Boxed warning, Warnings, Adverse reactions | QTG126297Q |
| DICLOFENAC SODIUM | DICLOFENAC SODIUM | INNOVUS PHARMACEUTICALS, INC. | ad9d2c28-21bc-4f81-9c90-cce6a96d976a | 2025-03-25 | Warnings | QTG126297Q |
| Diclofenac Sodium | DICLOFENAC SODIUM TOPICAL | Preferred Pharmaceuticals Inc. | 6d5243ae-4a1a-4583-9337-085520e1f14a | 2025-03-17 | Boxed warning, Warnings, Adverse reactions | QTG126297Q |
| Diclofenac Sodium Delayed Release | DICLOFENAC SODIUM | Preferred Pharmaceuticals Inc. | c933eaad-ba53-4130-90db-a66f89dfc29f | 2025-03-14 | Boxed warning, Warnings, Adverse reactions | QTG126297Q |
| Diclofenac Sodium | DICLOFENAC SODIUM | Oceanside Pharmaceuticals | c48113e0-9f1e-4086-b18f-3204c0d2a689 | 2025-03-13 | Boxed warning, Warnings, Adverse reactions | QTG126297Q |
| Diclofenac sodium | DICLOFENAC SODIUM | Cipla USA Inc. | daf52f5a-1bb7-4808-ab98-483ab9e8cfa0 | 2025-03-11 | Warnings | QTG126297Q |
| Diclofenac sodium | DICLOFENAC SODIUM | Alembic Pharmaceuticals Limited | 048ede6a-b7cd-4100-8979-519bd44906c8 | 2025-03-11 | Boxed warning, Warnings, Adverse reactions | QTG126297Q |
| Diclofenac Sodium | DICLOFENAC SODIUM | Preferred Pharmaceuticals Inc. | 31b56330-6870-48b7-a8c4-0639e0766b25 | 2025-03-06 | Boxed warning, Warnings, Adverse reactions | QTG126297Q |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.